Cargando…

Early detection of Alzheimer's disease: new diagnostic criteria

There has been unprecedented growth of scientific knowledge about Alzheimer's disease (AD), The description of distinctive and reliable biomarkers that are now available through structural brain imaging with magnetic resonance imaging, molecular neuroimaging with positron emission tomography, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubois, Bruno, Picard, Gaetane, Sarazin, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2009
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181912/ https://www.ncbi.nlm.nih.gov/pubmed/19585949

Ejemplares similares

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
por: Hadar, Adva, et al.
Publicado: (2018)

Clinical and research value of the new diagnostic criteria for Alzheimer’s disease
por: Wei, CHEN
Publicado: (2015)

CCCDTD5: research diagnostic criteria for Alzheimer's Disease
por: Gauthier, Serge, et al.
Publicado: (2020)

Alzheimer's disease diagnostic criteria: practical applications
por: Cummings, Jeffrey
Publicado: (2012)

Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets
por: de Launay, Daphne, et al.
Publicado: (2011)

Mechanism-based treatments for Alzheimer's disease
por: Davies, Peter, et al.
Publicado: (2009)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
por: Millan, Mark J.
Publicado: (2014)

Perleche, a New Parasitic Disease of Children
por: Campbell, F. R.
Publicado: (1886)

Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential
por: Flood, B, et al.
Publicado: (2015)

Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group
por: Perneczky, Robert, et al.
Publicado: (2016)

Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers
por: Kloosterman, Manon, et al.
Publicado: (2023)

Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease?
por: Blennow, Kaj, et al.
Publicado: (2010)

Still debating a cause and diagnostic criteria for Alzheimer's disease
por: Popescu, Bogdan O
Publicado: (2007)

Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: A feasibility study
por: Boutet, Claire, et al.
Publicado: (2014)

The New Criteria for Alzheimer’s Disease - Implications for Geriatricians(*)
por: Molin, Pierre, et al.
Publicado: (2016)

Frontal presentation of Alzheimer's disease: a series of patients with biological evidence by CSF biomarkers
por: de Souza, Leonardo Cruz, et al.
Publicado: (2013)

The Emergence of a New Conceptual Framework for Alzheimer’s Disease
por: Dubois, Bruno
Publicado: (2018)

New Instruments
Publicado: (1893)

Applying New Research Criteria for Diagnosis of Early Alzheimer's Disease: Sex and Intelligence Matter
por: Beinhoff, U., et al.
Publicado: (2009)

Long-Term Retention Deficit Involvement in Prodromal Alzheimer’s Disease
por: Jonin, P. Y., et al.
Publicado: (2010)

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
por: Moss, Donald E, et al.
Publicado: (2013)

A New Tæniafuge
por: Campi, Numa, et al.
Publicado: (1886)

New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
por: Kiritani, Sho, et al.
Publicado: (2023)

Establishing Criteria for Human Mesenchymal Stem Cell Potency
por: Samsonraj, Rebekah M., et al.
Publicado: (2015)

On Some New Local Anesthetics
por: Braun, H.
Publicado: (1906)

Some New Lanoline Ointments
por: Stern, E., et al.
Publicado: (1889)

New Facts about Antipirine
Publicado: (1885)

Early alteration of the locus coeruleus in phenotypic variants of Alzheimer’s disease
por: Olivieri, Pauline, et al.
Publicado: (2019)

A New Procedure with the Paraffine Method
por: Krauss, William C.
Publicado: (1888)

Modeling Early Radiation DNA Damage Occurring During (177)Lu-DOTATATE Radionuclide Therapy
por: Tamborino, Giulia, et al.
Publicado: (2022)

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center
por: Mittal, Abhenil, et al.
Publicado: (2021)

Illumination of the Cavities of the Body by a New Instrument—Nitsche
por: Osterday, A.
Publicado: (1879)

A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer
por: Annaházi, Anita, et al.
Publicado: (2016)

Are the revised diagnostic criteria for Alzheimer’s disease useful in low- and middle-income countries?
por: Cece, YANG, et al.
Publicado: (2015)

MicroRNA-Based Diagnostics in Heart Diseases: Current Limitations and Future Perspectives
por: Düsing, Philip, et al.
Publicado: (2021)

Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
por: Ferreira, Daniel, et al.
Publicado: (2014)

Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease
por: Janssens, Peter, et al.
Publicado: (2021)

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
por: Janel, N, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4cg2dj7mco0mrf9sul1tlnst4f